Skip to content
Mikä on POC-tutkimus?

POC study

The POC study makes it possible to determine whether the miscarriage was due to a chromosomal abnormality.

Unfortunately, some clinically diagnosed pregnancies end prematurely, the majority of which end already during the first trimester. More than 50% of these cases are due to chromosomal abnormalities.

All foetal cells must have two copies of each chromosome, one from the mother’s egg and one from the father’s sperm. In total, each cell must contain 46 chromosomes. Chromosomal abnormalities resulting from an incorrect number of chromosomes can lead to miscarriage.

The product of conception (POC) study makes it possible to determine whether the miscarriage was due to a chromosomal abnormality. The study determines all chromosomes in the miscarriage tissue with the NGS technology. In addition to the tissue sample, a blood sample from the mother is needed.

What are the benefits of a POC study?

The study is highly reliable and results are obtained in 99% of cases. The study is particularly useful in the case of repeated miscarriages or after fertility treatments.

The research result can be used in the selection of treatment methods, for example, preimplantation genetic diagnosis can be used to examine the embryo’s chromosomes before the embryo is transferred to the uterus. The results of the study are reviewed and the necessary follow-up measures are planned at an appointment.

For more information about the POC study, contact our customer service or leave us a contact request.

Read more

Why Felicitas Mehiläinen

Felicitas Mehiläinen is the leading fertility clinic in Finland providing a wide variety of fertility treatments ranging from basic infertility care to the most advanced IVF technology available today.
Over 30 years of experience has made it possible for the Felicitas Mehiläinen to offer the highest standards of patient care and reproductive health services in a modern and comfortable clinic.
Our doctors and scientists have always been at the forefront of IVF science and development; in fact, our founder, was part of the team involved in the birth of the Finland’s first IVF baby in 1984.
We always remain focused on the individual needs of each and every patient. We always put out patients first, and that is why we work so hard to listen to and treat every patient individually.